Exagen Inc. XGN Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 58.3%-1.0pp | 58.3%-1.2pp | 59.9%+1.1pp | 59.4%+0.3pp | 59.3%+0.5pp | |
| Operating margin | -20.6%+4.0pp | -21.1%+3.4pp | -19.6%+8.0pp | -23.9%+4.0pp | -24.7%+7.9pp | |
| Net margin | -29.5%-2.2pp | -30%-2.8pp | -29.9%+0.4pp | -28.8%+1.7pp | -27.3%+7.4pp | |
| Returns | ||||||
| Return on equity | -193.6%-76.1pp | -147.8%-54.1pp | -122.8%-39.0pp | -87.9%-18.0pp | -117.5%-48.3pp | |
| Return on invested capital | -73.7%+7.6pp | -120.5%+11.0pp | -102.9%-21.4pp | -85.6%-10.5pp | -81.3%+22.8pp | |
| Efficiency | ||||||
| Asset turnover | 1.5×+0.2× | 1.3×+0.2× | 1.2×+0.1× | 1.1×+0.1× | 1.2×+0.4× | |
| Liquidity | ||||||
| Current ratio | 3.5×+1.1× | 3.5×+0.8× | 4.1×0.0× | 5×+0.6× | 2.3×-2.5× | |
| Leverage | ||||||
| Debt-to-equity | 1.9×-1.8× | 1.6×-0.9× | 1.5×-0.3× | 1.2×-0.2× | 3.7×+2.5× | |
| Per Share | ||||||
| Book value per share | $0.61+75.4% | $0.81+54.4% | $0.79+12.2% | $1.00+3.1% | $0.35-69.0% | |
| Valuation | ||||||
| Market capitalization | $112.34M-26.5% | $137.79M+90.5% | $241.82M+331% | $154.34M+373% | $64.25M+127% | |
| Price / sales | 1.6×-1.0× | 2.1×+0.8× | 3.8×+2.8× | 2.6×+2.0× | 1.1×+0.6× | |
| Price / book | 7.8×+0.5× | 7.9×+0.3× | 13.3×+9.0× | 7.3×+5.5× | 10×+8.6× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Exagen Inc.'s profit margins?
- Exagen Inc. (XGN) runs a 58.3% gross margin and a -20.6% operating margin, with a -29.5% net margin.
- Where do Exagen Inc.'s ratios come from?
- Every ratio is computed from Exagen Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
